Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Current Assets (2019 - 2025)

Historic Current Assets for Legend Biotech (LEGN) over the last 7 years, with Q3 2025 value amounting to $1.2 billion.

  • Legend Biotech's Current Assets fell 800.22% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year decrease of 800.22%. This contributed to the annual value of $1.3 billion for FY2024, which is 1427.97% down from last year.
  • Per Legend Biotech's latest filing, its Current Assets stood at $1.2 billion for Q3 2025, which was down 800.22% from $1.2 billion recorded in Q2 2025.
  • Legend Biotech's 5-year Current Assets high stood at $1.6 billion for Q2 2023, and its period low was $475074.0 during Q1 2021.
  • Its 5-year average for Current Assets is $1.1 billion, with a median of $1.2 billion in 2025.
  • Per our database at Business Quant, Legend Biotech's Current Assets surged by 18184996.99% in 2022 and then tumbled by 1427.97% in 2024.
  • Quarter analysis of 5 years shows Legend Biotech's Current Assets stood at $949.8 million in 2021, then grew by 15.72% to $1.1 billion in 2022, then skyrocketed by 36.27% to $1.5 billion in 2023, then decreased by 14.28% to $1.3 billion in 2024, then dropped by 3.26% to $1.2 billion in 2025.
  • Its Current Assets was $1.2 billion in Q3 2025, compared to $1.2 billion in Q2 2025 and $1.2 billion in Q1 2025.